Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$45K Buy
3,396
+291
+9% +$3.83K ﹤0.01% 6959
2014
Q2
$40K Sell
3,105
-7,282
-70% -$101K ﹤0.01% 7152
2014
Q1
$162K Sell
10,387
-18,708
-64% -$282K ﹤0.01% 5433
2013
Q4
$519K Buy
29,095
+25,669
+749% +$447K ﹤0.01% 4287
2013
Q3
$55K Buy
3,426
+779
+29% +$11.9K ﹤0.01% 6744
2013
Q2
$39K Buy
+2,647
New +$41.4K ﹤0.01% 7038

Other funds holding BAK

UBS's BAK Position: Q3 2014 in Review

UBS increased its Braskem (BAK) stake by 9.4% in Q3 2014, buying an estimated $3.83K and bringing the position to 3,396 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #6959.

UBS first reported a position in BAK in Q2 2013 and has held it in 6 quarters since. The position peaked at $519K in Q4 2013. 55 funds tracked by Wall St. Rank hold BAK as of Q3 2014.

  • UBS held 3,396 shares of Braskem worth $45K as of Q3 2014.
  • UBS bought 291 Braskem shares in Q3 2014, an estimated $3.83K.
  • Braskem made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6959 holding.
  • UBS first reported a position in Braskem in Q2 2013 and has held it in 6 quarters since.
  • UBS's Braskem position peaked at $519K in Q4 2013.
  • 55 funds tracked by Wall St. Rank held Braskem as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.